Reporting owner · Q3 2026 · CIK 1730048

Hopkinson Craig C.: insider trades.

Hopkinson Craig C. reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.3M), across 1 company.

Transactions
8
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
Hopkinson Craig C.

Companies

CompanyRelationshipTransactions
Alkermes plc. (ALKS)Officer · EVP R&D, Chief Medical Officer8

Transactions

8 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-01Alkermes plc.S9,000$46.9965,389Form 4
2026-09-01Alkermes plc.M5,000$24.5974,389Form 4
2026-08-03Alkermes plc.S9,000$48.5869,389Form 4
2026-08-03Alkermes plc.M4,896$24.5978,389Form 4
2026-08-03Alkermes plc.M104$19.3473,493Form 4
2026-07-01Alkermes plc.S700$52.1373,389Form 4
2026-07-01Alkermes plc.S8,300$51.4674,089Form 4
2026-07-01Alkermes plc.M5,000$19.3482,389Form 4

Questions

What stock did Hopkinson Craig C. buy or sell?

Hopkinson Craig C. reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.3M), across 1 company.

Is Hopkinson Craig C. the same person as other filers with this name?

This page covers SEC CIK 1730048 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/hopkinson-craig-c-1730048.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.